iRadimed Corporation (IRMD): Price and Financial Metrics

IRMD POWR Grades

• IRMD scores best on the Sentiment dimension, with a Sentiment rank ahead of 98.49% of US stocks.
• The strongest trend for IRMD is in Growth, which has been heading up over the past 179 days.
• IRMD's current lowest rank is in the Momentum metric (where it is better than 6.83% of US stocks).

IRMD Stock Summary

• Price to trailing twelve month operating cash flow for IRMD is currently 45.77, higher than 91.42% of US stocks with positive operating cash flow.
• IRMD's price/sales ratio is 10.75; that's higher than the P/S ratio of 90.3% of US stocks.
• IRMD's equity multiplier -- a measure of assets relative to shareholders'equity -- is greater than that of merely 11.66% of US stocks.
• Stocks with similar financial metrics, market capitalization, and price volatility to IRADIMED CORP are LXFR, AVNS, PWFL, ARTW, and HAE.
• IRMD's SEC filings can be seen here. And to visit IRADIMED CORP's official web site, go to www.iradimed.com.

IRMD Valuation Summary

• IRMD's price/sales ratio is 10.5; this is 377.27% higher than that of the median Healthcare stock.
• IRMD's price/earnings ratio has moved down 1.1 over the prior 108 months.

Below are key valuation metrics over time for IRMD.

IRMD Growth Metrics

Its year over year net income to common stockholders growth rate is now at 956.65%.
• Its 5 year net income to common stockholders growth rate is now at 103.32%.
• The 2 year net income to common stockholders growth rate now stands at 9.11%.

The table below shows IRMD's growth in key financial areas (numbers in millions of US dollars).

IRMD's Quality Factors

• IRMD has a Quality Grade of A, ranking ahead of 97.83% of graded US stocks.
• IRMD's asset turnover comes in at 0.488 -- ranking 96th of 186 Medical Equipment stocks.
• DYNT, NUVA, and ELMD are the stocks whose asset turnover ratios are most correlated with IRMD.

The table below shows IRMD's key quality metrics over time.